EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dysregulation of Arachidonic Acid Metabolism Drives Inflammatory Lipid Production in Localized Provoked Vulvodynia

Sarah A Fischer, Oluwademilade Oladele, Zahra Mahamed, Emanuelle Chrysilla iD, Anna Baumer, Tamari Bekauri iD, Krishna Rao Maddipati, Tanzy Love iD, Mitchell Linder iD, Megan Falsetta iD

Nutrients · 2025

DOI: 10.3390/nu17132233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Sarah A Fischer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Rochester, Rochester, NY 14642, USA. Hauptthemen laut MEDLINE: Arachidonic Acid, Vulvodynia, Inflammation, Lipid Metabolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIH HHS, NIH-NICHD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Localized provoked vulvodynia (LPV) is characterized by chronic vulvar pain upon light touch to the vestibule, a specialized ring of tissue immediately surrounding the vaginal opening. LPV affects about 14 million people in the US, yet the etiopathology of the disease is unknown. In LPV, the vestibule expresses elevated levels of the pro-nociceptive pro-inflammatory mediators prostaglandin E2 (PGE2) and interleukin-6 (IL-6), which corresponds to lower pain thresholds. Previous studies have shown reduced amounts of arachidonic acid (AA)-derived pro-resolving lipid mediators in tissue biopsies from LPV patients that might impede the resolution of inflammation. AA is obtained from dietary linoleic acid, pointing to a defect in the metabolism of dietary polyunsaturated fatty acids in LPV. We aimed to further explore the involvement of AA metabolism in LPV, which appears dysregulated in the vestibule of LPV patients and culminates in chronic inflammation and chronic pain.

Methods

Vestibular and vulvar tissue biopsies obtained from LPV and non-LPV patients were used to generate fibroblast strains and assessed for COX/LOX expression using qRT-PCR. Fibroblast strains were treated with inflammatory stimuli, and then COX-1 and COX-2 expression was assessed using Western blot analysis. Pro-inflammatory mediator production was assessed using enzyme-linked immunosorbent assays (ELISAs). ALOX5 and ALOX12 expression was assessed using qRT-PCR. Finally, lipidomic analysis was carried out to screen for 143 lipid metabolites following inflammatory challenge.

Results

Tissue and fibroblasts from LPV patients exhibited altered expression of COX/LOX enzymes and production of AA-derived lipid mediators compared to non-LPV patients.

Conclusions

Lipid profiles of tissue and vestibular fibroblasts from LPV patients differed from non-LPV patients, and this difference was attributed to differential COX/LOX expression and activity, which metabolizes AA derived from dietary linoleic acid. This dysregulation fosters chronic inflammation and reduced resolution capacity in LPV patients, causing chronic pain. While further work is needed, these findings suggest that dietary modifications could impact the LPV mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arachidonic AcidVulvodyniaInflammationLipid MetabolismHumansFemaleAdultFibroblastsCyclooxygenase 2DinoprostoneCyclooxygenase 1Middle AgedInterleukin-6Inflammation MediatorsLinoleic Acid

Stichwörter der Autor:innen

12-LOXCOX-1COX-2arachidonic acidchronic paininflammationlipid metabolismlocalized provoked vulvodyniaspecialized pro-resolving mediators

Substanzen

Arachidonic AcidCyclooxygenase 2DinoprostoneCyclooxygenase 1Interleukin-6Inflammation MediatorsLinoleic Acid

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of Rochester, Rochester, NY 14642, USA.
  • Department of Pharmacology and Physiology, University of Rochester, Rochester, NY 14642, USA.
  • Lipidomics Core Facility and Bioactive Lipids Research Program, Wayne State University, Detroit, MI 48202, USA.
  • Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY 14642, USA.

ORCID-Profile: Emanuelle Chrysilla, Tamari Bekauri, Tanzy Love, Mitchell Linder, Megan Falsetta

Förderung

  • NICHD NIH HHS
  • NIH HHS
  • NIH-NICHD
  • NIH

Zitieren

APA

Fischer, S. A., Oladele, O., Mahamed, Z., Chrysilla, E., Baumer, A., Bekauri, T., Maddipati, K. R., Love, T., Linder, M., & Falsetta, M. (2025). Dysregulation of Arachidonic Acid Metabolism Drives Inflammatory Lipid Production in Localized Provoked Vulvodynia. Nutrients. https://doi.org/10.3390/nu17132233

Vancouver

Fischer SA, Oladele O, Mahamed Z, Chrysilla E, Baumer A, Bekauri T, et al. Dysregulation of Arachidonic Acid Metabolism Drives Inflammatory Lipid Production in Localized Provoked Vulvodynia. Nutrients. 2025. doi:10.3390/nu17132233

BibTeX
@article{Fischer2025,
  author = {Fischer, Sarah A and Oladele, Oluwademilade and Mahamed, Zahra and Chrysilla, Emanuelle and Baumer, Anna and Bekauri, Tamari and Maddipati, Krishna Rao and Love, Tanzy and Linder, Mitchell and Falsetta, Megan},
  title = {Dysregulation of Arachidonic Acid Metabolism Drives Inflammatory Lipid Production in Localized Provoked Vulvodynia},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17132233}
}
Kostenlos starten →